News

NYC Chinatown
Straight Talk: Connecting with Patients in Their Own Languages

Services including a pilot program for remote simultaneous medical interpreting using UN-style headsets can help improve care for a growing number of patients.

Thursday, February 19, 2015
Christina Leslie and John Petrini
Expanding the Impact of Precision Medicine to Fuel Discoveries

MSK’s Functional Genomics Initiative will enable basic scientists to take full advantage of the massive amount of data produced by tumor sequencing.

Thursday, February 12, 2015
the fibrous extensions of a nerve cell (red) and an oligodendrocyte (green) growing on top of the nerve cell
Can Stem Cells Be Taught to Repair a Radiation-Damaged Brain?

In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation.

Thursday, February 5, 2015
Report Highlights Advances Made at MSK That Are Changing Patients’ Lives

An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.

Wednesday, January 28, 2015
Neurons created from embryonic stem cells
Seeing the Light: How Engineered Nerve Cells Might Curb Parkinson’s Disease

A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells.

Thursday, January 22, 2015
Stained pathology slides of a patient’s tumor (right) and of an organoid made from that tumor (left).
Five Fascinating Approaches to Cancer Science

From tropical plants and 3-D snapshots of worms to tiny particles that light up tumors, here’s a glimpse at some of the fascinating work MSK researchers pursued in 2014 as part of our quest to advance cancer science.

Tuesday, December 30, 2014
Pictured: Viviane Tabar
Investigators Use Stem Cells to Study Rare Pediatric Brain Tumors

Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.

Monday, December 1, 2014
Pictured: Jedd Wolchok, Alexandra Snyder Charen and Timothy Chan
New Findings Clarify How Immunotherapy Works — and Why, In Some People, It Doesn’t

In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system.

Thursday, November 20, 2014
Michel Sadelain and Prasad Adusumilli
Immunotherapy Shows Promise for Treating Solid Tumors in the Chest

A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs.

Wednesday, November 19, 2014
(From left) MSK investigators Michael Berger, José Baselga, and Maurizio Scaltriti, and graduate student Pau Castel.
Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.

Monday, November 17, 2014